WO2023052808 - GEL CONTAINING DUAL L-CARNOSINE/ALOE VERA NANOPHYTOSOMES FOR ACCELERATING DIABETIC WOUND HEALING
National phase entry is expected:
Publication Number
WO/2023/052808
Publication Date
06.04.2023
International Application No.
PCT/IB2021/058812
International Filing Date
28.09.2021
Title **
[English]
GEL CONTAINING DUAL L-CARNOSINE/ALOE VERA NANOPHYTOSOMES FOR ACCELERATING DIABETIC WOUND HEALING
[French]
GEL CONTENANT DES NANOPHYTOSOMES DOUBLES DE L-CARNOSINE/ALOE VERA POUR ACCÉLÉRER LA CICATRISATION DES PLAIES DIABÉTIQUES
Applicants **
DARVISHI, Behrad
Inventors
AGHAMIRI, Helia
SHARIFI, Ali Mohammad
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1878 | |
| EPO | Filing, Examination, Granting | 8666 | |
| Japan | Filing, Examination, Granting | 1992 | |
| South Korea | Filing, Examination, Granting | 1605 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,881
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
whole leaf extract and L-Carnosine in management of different types of wound, especially the ones associates with diabetes by providing anti-inflammatory, soothing, antimicrobial, analgesic, proangiogenic effects and cyto-protective activity on proliferative cells in the wound site.[French]
et de la L-carnosine dans la prise en charge de différents types de plaie, en particulier ceux associées au diabète en présentant des activités anti-inflammatoires, apaisantes, antimicrobiennes, analgésiques, pro-angiogéniques et cytoprotectrices sur des cellules prolifératives dans le site de la plaie.